Abstract:Genetically-encoded libraries (GEL) are increasingly used for discovery of ligands for ‘undruggable’ targets that cannot be addressed with small molecules. Foundational GEL platforms like phage-, yeast-, ribosome- and mRNA-display enabled display of libraries composed of 20 natural amino acids (20AA). Today, numerous strategies expand GEL beyond 20AA space by incorporating unnatural amino acids (UAA) and chemical post-translational modification (cPTM) to build linear, cyclic, and bicyclic peptides. The standard operating procedure for UAA and cPTM libraries starts from a "naïve" chemically-upgraded library with 108-1012 compounds, uses target of interest and rounds of selection to narrow down to a set of receptor binding hits. However, such approach uses zero knowledge of natural peptide-receptor interactions which already exists in libraries with 20AA space. There is currently no consensus whether ‘zero knowledge’ naïve libraries or libraries with pre-existing knowledge can offer a more effective path to discovery of molecular interactions. In this manuscript, we evaluated the feasibility of discovery of macrocyclic and bicyclic peptide from "non-zero knowledge" libraries. We approach this problem by late-stage chemical reshaping of phage-displayed landscape of 20AA binders to NS3aH1 protease. The re-shaping is performed under a novel multifunctional C2-symmetric linchpin, 3,5-bis(bromomethyl)benzaldehyde (termed KYL), that combines two electrophiles that react with thiols and aldehyde group that reacts with N-terminal amine. KYL diversified phage-displayed peptides into bicyclic architectures and delineates 2 distinct sequence populations: (i) peptides that retained binding upon bicyclization (ii) peptides that lost binding once chemically modified. Our report provides a case study for discovering advanced, chemically-upgraded macrocycles and bicycles from libraries with pre-existing knowledge. The results imply that thousands of selection campaigns completed in 20AA space, in principle, can serve for late-stage reshaping and as a starting point for discovery of advanced peptide-derived ligands.

An integrated platform approach enables discovery of potent, selective and ligand-competitive cyclic peptides targeting the GIP receptor

Screening macrocyclic peptide libraries by yeast display allows control of selection process and affinity ranking

Disulfide-constrained peptide scaffolds enable a robust peptide-therapeutic discovery platform

Recent Advances in Non‐Standard Macrocyclic Peptide Ligand Discovery using mRNA Display

Methods for generating and screening libraries of genetically encoded cyclic peptides in drug discovery

A Tag‐Free Platform for Synthesis and Screening of Cyclic Peptide Libraries

mRNA display in cell lysates enables identification of cyclic peptides targeting the BRD3 extraterminal domain

MOrPH-PhD: An Integrated Phage Display Platform for the Discovery of Functional Genetically Encoded Peptide Macrocycles

State-specific Peptide Design Targeting G Protein-coupled Receptors

Rapid in silico Design of Potential Cyclic Peptide Binders Targeting Protein-Protein Interfaces

Late-stage reshaping of phage-displayed libraries to macrocyclic and bicyclic landscapes using multipurpose linchpin

Integrated Computational Pipeline for the High-Throughput Discovery of Cell Adhesion Peptides.

Design, synthesis, and analysis of macrobicyclic peptides for targeting the Gαi protein

Discovery of GPCR ligands for probing signal transduction pathways

A phage-displayed disulfide constrained peptide discovery platform yields novel human plasma protein binders

mRNA display: ligand discovery, interaction analysis and beyond

The coming of age of cyclic peptide drugs: an update on discovery technologies

Polypharmacy through Phage Display: Selection of Glucagon and GLP-1 Receptor Co-agonists from a Phage-Displayed Peptide Library

A high-throughput platform for efficient exploration of functional polypeptide chemical space

Peptide Mold: A Novel Strategy for Mapping Potential Binding Sites in Protein Targets